• Je něco špatně v tomto záznamu ?

Breakthrough COVID-19 in vaccinated patients with hematologic malignancies: results from the EPICOVIDEHA survey

L. Pagano, J. Salmanton-García, F. Marchesi, O. Blennow, M. Gomes da Silva, A. Glenthøj, J. van Doesum, YM. Bilgin, A. López-García, F. Itri, R. Nunes Rodrigues, B. Weinbergerová, F. Farina, G. Dragonetti, C. Berg Venemyr, J. van Praet, O....

. 2022 ; 140 (26) : 2773-2787. [pub] 2022Dec29

Jazyk angličtina Země Spojené státy americké

Typ dokumentu časopisecké články

Perzistentní odkaz   https://www.medvik.cz/link/bmc23004869

Limited data are available on breakthrough COVID-19 in patients with hematologic malignancy (HM) after anti-severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccination. Adult patients with HM, ≥1 dose of anti-SARS-CoV-2 vaccine, and breakthrough COVID-19 between January 2021 and March 2022 were analyzed. A total of 1548 cases were included, mainly lymphoid malignancies (1181 cases, 76%). After viral sequencing in 753 cases (49%), the Omicron variant was prevalent (517, 68.7%). Most of the patients received ≤2 vaccine doses before COVID-19 (1419, 91%), mostly mRNA-based (1377, 89%). Overall, 906 patients (59%) received COVID-19-specific treatment. After 30-day follow-up from COVID-19 diagnosis, 143 patients (9%) died. The mortality rate in patients with the Omicron variant was 7.9%, comparable to other variants, with a significantly lower 30-day mortality rate than in the prevaccine era (31%). In the univariable analysis, older age (P < .001), active HM (P < .001), and severe and critical COVID-19 (P = .007 and P < .001, respectively) were associated with mortality. Conversely, patients receiving monoclonal antibodies, even for severe or critical COVID-19, had a lower mortality rate (P < .001). In the multivariable model, older age, active disease, critical COVID-19, and 2-3 comorbidities were correlated with a higher mortality, whereas monoclonal antibody administration, alone (P < .001) or combined with antivirals (P = .009), was protective. Although mortality is significantly lower than in the prevaccination era, breakthrough COVID-19 in HM is still associated with considerable mortality. Death rate was lower in patients who received monoclonal antibodies, alone or in combination with antivirals.

Admiraal de Ruyter Hospital Goes the Netherlands

Algemeen Ziekenhuis Klina VZW Brasschaat Belgium

Amsterdam UMC location VUmc Amsterdam the Netherlands

Azienda Ospedaliera Nazionale SS Antonio e Biagio e Cesare Arrigo Alessandria Italy

Azienda Ospedaliera San Gerardo Monza Monza Italy

Azienda Ospedaliero Universitaria Consorziale Policlinico di Bari Bari Italy

CHU Montpellier Montpellier France

Clinical and Translational Fungal Working Group University of California San Diego La Jolla CA

Clinical Hospital Center Rijeka Rijeka Croatia

Clinical Microbiology and Infectious Diseases Department Hospital General Universitario Gregorio Marañón Madrid Spain

Cochin Hospital Assistance Publique Hôpitaux de Paris Paris France

Complejo Hospitalario de Navarra Iruña Pamplona Spain

COVID hospital Batajnica Belgrade Serbia

Croatian Cooperative Group for Hematological Diseases Croatia

Departament de Medicina Universitat Autònoma de Barcelona Bellaterra Spain

Department 1 of Internal Medicine Faculty of Medicine and University Hospital Cologne Excellence Center for Medical Mycology University of Cologne Cologne Germany

Department of Haematology Blood Neoplasms and Bone Marrow Transplantation Wroclaw Medical University Wroclaw Poland

Department of Hematological Medicine King's College Hospital NHS Foundation Trust Kings College London and Anthony Nolan London United Kingdom

Department of Hematology and Oncology Medical University of Innsbruck Innsbruck Austria

Department of Hematology Copenhagen University Hospital Rigshospitalet Copenhagen Denmark

Department of Hematology Hospital Universitario de Burgos Burgos Spain

Department of Hematology University Hospital Virgen Macarena University Hospital Virgen del Rocío Instituto de Biomedicina de Sevilla Seville Spain

Department of Hematology Vall d'Hebron Hospital Universitari Experimental Hematology Vall d'Hebron Institute of Oncology Vall d'Hebron Barcelona Hospital Campus Barcelona Spain

Department of Infectious Diseases Karolinska University Hospital Stockholm Sweden

Department of Internal Medicine Federal University of Rio de Janeiro Rio de Janeiro Brazil

Department of Internal Medicine Hematology and Oncology University Hospital Brno Brno Czech Republic

Department of Internal Medicine South Division Faculty of Medicine University of Szeged Szeged Hungary

Department of Medicine and Surgery University of Insubria and ASST Sette Laghi Ospedale di Circolo of Varese Varese Italy

Department of Nephrology and Infectious diseases AZ Sint Jan Brugge Oostende AV Brugge Belgium

Department of Oncology Hematology and Bone Marrow Transplantation with Section of Pneumology University Medical Center Hamburg Eppendorf Hamburg Germany

Department of Physiology Faculty of Medicine Masaryk University Brno Czech Republic

Division of Hematology Department of Internal Medicine University of Debrecen Debrecen Hungary

Division of Infectious Diseases and Global Public Health Department of Medicine University of California San Diego San Diego CA

Division of Infectious Diseases Department of Internal Medicine Medical University of Graz Graz Austria

Dokuz Eylul University Division of Hematology Izmir Turkey

Ematologia con Trapianto Ospedale Dimiccoli Barletta Barletta Italy

Faculty of Medicine and University Hospital Cologne Center for Molecular Medicine Cologne University of Cologne Cologne Germany

Faculty of Medicine and University Hospital Cologne Chair Translational Research Cologne Excellence Cluster on Cellular Stress Responses in Aging Associated Diseases University of Cologne Cologne Germany

Faculty of Medicine and University Hospital Cologne Clinical Trials Centre Cologne University of Cologne Cologne Germany

Faculty of Medicine and University Hospital Cologne Cologne Excellence Cluster on Cellular Stress Responses in Aging Associated Diseases University of Cologne Cologne Germany

Faculty of Medicine University of Zagreb Zagreb Croatia

Fondazione IRCCS Istituto Nazionale dei Tumori Milan Italy

Fundación Jimenez Diaz University Hospital Health Research Institute IIS FJD Madrid Spain

German Centre for Infection Research Partner Site Bonn Cologne Cologne Germany

Hematology and Stem Cell Transplant Unit IRCCS Regina Elena National Cancer Institute Rome Italy

Hematology Department Hospital Universitario de Salamanca Salamanca Spain

Hematology Unit ASST Spedali Civili Brescia Italy

Hematology Unit Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico Milan Italy

Hematology Unit Fondazione Policlinico Universitario Agostino Gemelli IRCCS Rome Italy

Hematology Unit Università Cattolica del Sacro Cuore Rome Italy

Hopital Saint Louis Paris France

Hospital Escuela de Agudos Dr Ramón Madariaga Posadas Argentina

Hospital Nuestra Señora de Sonsoles Ávila Spain

Hospital Universitario Infanta Leonor Madrid Spain

Hospital Universitario Marqués de Valdecilla Santander Spain

Hospital University of Parma Hematology and Bone Marrow Unit Parma Italy

Institute of Hematology and Blood Transfusion Prague Czech Republic

Instituto de Investigación Biomédica de Salamanca Centro de Investigación del Cáncer IBMCC Salamanca Spain

IRCCS Ospedale San Raffaele Milan Italy

Istituto Oncologico della Svizzera Italiana Bellinzona Switzerland

La Paz University Hospital Madrid Spain

Laikon Hospital Athens Greece

Marmara University Istanbul Turkey

Medizinische Klinik 2 Klinikum rechts der Isar TU München Munich Germany

Northumbria Healthcare Newcastle United Kingdom

Ospedale Vito Fazzi Lecce Italy

Portuguese Institute of Oncology Lisbon Portugal

San Luigi Gonzaga Hospital Orbassano Orbassano Italy

Stem Cell Transplant Center AOU Citta' della Salute e della Scienza Turin Italy

Università Milano Bicocca Milan Italy

Universitätsklinikum Hamburg Eppendorf Hamburg Germany

University Clinic of Hematology Skopje North Macedonia

University Hospital Centre Zagreb Zagreb Croatia

University Hospital Dubrava Zagreb Croatia

University Hospital Olomouc Olomouc Czech Republic

University Medical Center Groningen Groningen the Netherlands

University of Milan and Fondazione IRCCS Istituto Nazionale dei Tumori Milan Italy

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc23004869
003      
CZ-PrNML
005      
20230425171752.0
007      
ta
008      
230418s2022 xxu f 000 0|eng||
009      
AR
024    7_
$a 10.1182/blood.2022017257 $2 doi
035    __
$a (PubMed)36126318
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xxu
100    1_
$a Pagano, Livio $u Hematology Unit, Fondazione Policlinico Universitario Agostino Gemelli - IRCCS, Rome, Italy $u Hematology Unit, Università Cattolica del Sacro Cuore, Rome, Italy $1 https://orcid.org/000000018287928X
245    10
$a Breakthrough COVID-19 in vaccinated patients with hematologic malignancies: results from the EPICOVIDEHA survey / $c L. Pagano, J. Salmanton-García, F. Marchesi, O. Blennow, M. Gomes da Silva, A. Glenthøj, J. van Doesum, YM. Bilgin, A. López-García, F. Itri, R. Nunes Rodrigues, B. Weinbergerová, F. Farina, G. Dragonetti, C. Berg Venemyr, J. van Praet, O. Jaksic, T. Valković, I. Falces-Romero, S. Martín-Pérez, M. Jiménez, J. Dávila-Valls, M. Schönlein, E. Ammatuna, S. Meers, M. Delia, Z. Stojanoski, A. Nordlander, T. Lahmer, L. Imre Pinczés, C. Buquicchio, K. Piukovics, I. Ormazabal-Vélez, N. Fracchiolla, M. Samarkos, GA. Méndez, JÁ. Hernández-Rivas, I. Espigado, M. Cernan, V. Petzer, S. Lamure, R. di Blasi, J. Marques de Almedia, M. Dargenio, MM. Biernat, M. Sciumè, C. de Ramón, N. de Jonge, J. Batinić, A. Aujayeb, M. Marchetti, G. Fouquet, N. Fernández, G. Zambrotta, MV. Sacchi, A. Guidetti, F. Demirkan, L. Prezioso, Z. Ráčil, M. Nucci, M. Mladenović, R. Liévin, M. Hanáková, S. Gräfe, U. Sili, M. Machado, C. Cattaneo, T. Adžić-Vukičević, L. Verga, J. Labrador, L. Rahimli, M. Bonanni, F. Passamonti, A. Pagliuca, P. Corradini, M. Hoenigl, P. Koehler, A. Busca, OA. Cornely
520    9_
$a Limited data are available on breakthrough COVID-19 in patients with hematologic malignancy (HM) after anti-severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccination. Adult patients with HM, ≥1 dose of anti-SARS-CoV-2 vaccine, and breakthrough COVID-19 between January 2021 and March 2022 were analyzed. A total of 1548 cases were included, mainly lymphoid malignancies (1181 cases, 76%). After viral sequencing in 753 cases (49%), the Omicron variant was prevalent (517, 68.7%). Most of the patients received ≤2 vaccine doses before COVID-19 (1419, 91%), mostly mRNA-based (1377, 89%). Overall, 906 patients (59%) received COVID-19-specific treatment. After 30-day follow-up from COVID-19 diagnosis, 143 patients (9%) died. The mortality rate in patients with the Omicron variant was 7.9%, comparable to other variants, with a significantly lower 30-day mortality rate than in the prevaccine era (31%). In the univariable analysis, older age (P < .001), active HM (P < .001), and severe and critical COVID-19 (P = .007 and P < .001, respectively) were associated with mortality. Conversely, patients receiving monoclonal antibodies, even for severe or critical COVID-19, had a lower mortality rate (P < .001). In the multivariable model, older age, active disease, critical COVID-19, and 2-3 comorbidities were correlated with a higher mortality, whereas monoclonal antibody administration, alone (P < .001) or combined with antivirals (P = .009), was protective. Although mortality is significantly lower than in the prevaccination era, breakthrough COVID-19 in HM is still associated with considerable mortality. Death rate was lower in patients who received monoclonal antibodies, alone or in combination with antivirals.
650    _2
$a dospělí $7 D000328
650    _2
$a lidé $7 D006801
650    12
$a COVID-19 $x epidemiologie $x prevence a kontrola $7 D000086382
650    _2
$a SARS-CoV-2 $7 D000086402
650    _2
$a testování na COVID-19 $7 D000086742
650    12
$a hematologické nádory $x komplikace $x terapie $7 D019337
650    _2
$a monoklonální protilátky $7 D000911
650    _2
$a antivirové látky $7 D000998
650    _2
$a protilátky virové $7 D000914
655    _2
$a časopisecké články $7 D016428
700    1_
$a Salmanton-García, Jon $u Department I of Internal Medicine, Faculty of Medicine and University Hospital Cologne, Excellence Center for Medical Mycology, University of Cologne, Cologne, Germany $u Faculty of Medicine and University Hospital Cologne, Cologne Excellence Cluster on Cellular Stress Responses in Aging-Associated Diseases, University of Cologne, Cologne, Germany $1 https://orcid.org/0000000267668297
700    1_
$a Marchesi, Francesco $u Hematology and Stem Cell Transplant Unit, IRCCS Regina Elena National Cancer Institute, Rome, Italy $1 https://orcid.org/0000000163532272
700    1_
$a Blennow, Ola $u Department of Infectious Diseases, Karolinska University Hospital, Stockholm, Sweden $1 https://orcid.org/0000000271677882
700    1_
$a Gomes da Silva, Maria $u Portuguese Institute of Oncology, Lisbon, Portugal $1 https://orcid.org/0000000269932450
700    1_
$a Glenthøj, Andreas $u Department of Hematology, Copenhagen University Hospital - Rigshospitalet, Copenhagen, Denmark $1 https://orcid.org/0000000320820738
700    1_
$a van Doesum, Jaap $u University Medical Center Groningen, Groningen, the Netherlands $1 https://orcid.org/0000000302143219
700    1_
$a Bilgin, Yavuz M $u Admiraal de Ruyter Hospital, Goes, the Netherlands $1 https://orcid.org/0000000348545424
700    1_
$a López-García, Alberto $u Fundación Jimenez Diaz University Hospital, Health Research Institute IIS-FJD, Madrid, Spain $1 https://orcid.org/0000000253545261
700    1_
$a Itri, Federico $u San Luigi Gonzaga Hospital - Orbassano, Orbassano, Italy $1 https://orcid.org/0000000235325281
700    1_
$a Nunes Rodrigues, Raquel $u Portuguese Institute of Oncology, Lisbon, Portugal $1 https://orcid.org/0000000283474281
700    1_
$a Weinbergerová, Barbora $u Department of Internal Medicine, Hematology and Oncology, University Hospital Brno, Brno, Czech Republic $1 https://orcid.org/0000000164602471
700    1_
$a Farina, Francesca $u IRCCS Ospedale San Raffaele, Milan, Italy $1 https://orcid.org/0000000251246970
700    1_
$a Dragonetti, Giulia $u Hematology Unit, Fondazione Policlinico Universitario Agostino Gemelli - IRCCS, Rome, Italy $1 https://orcid.org/0000000317756333
700    1_
$a Berg Venemyr, Caroline $u Department of Hematology, Copenhagen University Hospital - Rigshospitalet, Copenhagen, Denmark $1 https://orcid.org/0000000324615395
700    1_
$a van Praet, Jens $u Department of Nephrology and Infectious diseases, AZ Sint-Jan Brugge-Oostende AV, Brugge, Belgium $1 https://orcid.org/0000000271257001
700    1_
$a Jaksic, Ozren $u University Hospital Dubrava, Zagreb, Croatia $1 https://orcid.org/000000034026285X
700    1_
$a Valković, Toni $u Clinical Hospital Center Rijeka, Rijeka, Croatia
700    1_
$a Falces-Romero, Iker $u La Paz University Hospital, Madrid, Spain $1 https://orcid.org/0000000158887706
700    1_
$a Martín-Pérez, Sonia $u Hospital Nuestra Señora de Sonsoles, Ávila, Spain $1 https://orcid.org/0000000158097165
700    1_
$a Jiménez, Moraima $u Department of Hematology, Vall d'Hebron Hospital Universitari, Experimental Hematology, Vall d'Hebron Institute of Oncology, Vall d'Hebron Barcelona Hospital Campus, Barcelona, Spain $u Departament de Medicina, Universitat Autònoma de Barcelona, Bellaterra, Spain $1 https://orcid.org/0000000314448562
700    1_
$a Dávila-Valls, Julio $u Hospital Nuestra Señora de Sonsoles, Ávila, Spain $1 https://orcid.org/0000000251852073
700    1_
$a Schönlein, Martin $u Department of Oncology, Hematology and Bone Marrow Transplantation with Section of Pneumology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany $1 https://orcid.org/0000000210100975
700    1_
$a Ammatuna, Emanuele $u Departament de Medicina, Universitat Autònoma de Barcelona, Bellaterra, Spain $1 https://orcid.org/0000000182474901
700    1_
$a Meers, Stef $u Algemeen Ziekenhuis Klina VZW, Brasschaat, Belgium $1 https://orcid.org/0000000317542175
700    1_
$a Delia, Mario $u Azienda Ospedaliero-Universitaria Consorziale Policlinico di Bari, Bari, Italy $1 https://orcid.org/0000000264868912
700    1_
$a Stojanoski, Zlate $u University Clinic of Hematology, Skopje, North Macedonia $1 https://orcid.org/0000000175028356
700    1_
$a Nordlander, Anna $u Department of Infectious Diseases, Karolinska University Hospital, Stockholm, Sweden
700    1_
$a Lahmer, Tobias $u Medizinische Klinik II, Klinikum rechts der Isar, TU München, Munich, Germany $1 https://orcid.org/0000000310085311
700    1_
$a Imre Pinczés, László $u Division of Hematology, Department of Internal Medicine, University of Debrecen, Debrecen, Hungary $1 https://orcid.org/0000000304531709
700    1_
$a Buquicchio, Caterina $u Ematologia con Trapianto, Ospedale Dimiccoli Barletta, Barletta, Italy $1 https://orcid.org/0000000236835953
700    1_
$a Piukovics, Klára $u Department of Internal Medicine, South Division Faculty of Medicine University of Szeged, Szeged, Hungary $1 https://orcid.org/0000000344803131
700    1_
$a Ormazabal-Vélez, Irati $u Complejo Hospitalario de Navarra, Iruña-Pamplona, Spain $1 https://orcid.org/0000000311415546
700    1_
$a Fracchiolla, Nicola $u Hematology Unit, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy $1 https://orcid.org/0000000289828079
700    1_
$a Samarkos, Michail $u Laikon Hospital, Athens, Greece $1 https://orcid.org/0000000196309712
700    1_
$a Méndez, Gustavo-Adolfo $u Hospital Escuela de Agudos Dr. Ramón Madariaga, Posadas, Argentina $1 https://orcid.org/0000000305147004
700    1_
$a Hernández-Rivas, José-Ángel $u Hospital Universitario Infanta Leonor, Madrid, Spain $1 https://orcid.org/000000034550757X
700    1_
$a Espigado, Ildefonso $u Department of Hematology, University Hospital Virgen Macarena - University Hospital Virgen del Rocío, Instituto de Biomedicina de Sevilla (IBIS/CSIC), Universidad de Sevilla (Departamento de Medicina), Seville, Spain $1 https://orcid.org/0000000240436613
700    1_
$a Cernan, Martin $u University Hospital Olomouc, Olomouc, Czech Republic $1 https://orcid.org/0000000323451229 $7 xx0230369
700    1_
$a Petzer, Verena $u Department of Hematology and Oncology, Medical University of Innsbruck, Innsbruck, Austria $1 https://orcid.org/0000000292051440
700    1_
$a Lamure, Sylvain $u CHU Montpellier, Montpellier, France $1 https://orcid.org/000000015980305X
700    1_
$a di Blasi, Roberta $u Hopital Saint Louis, Paris, France $1 https://orcid.org/000000019001573X
700    1_
$a Marques de Almedia, Joyce $u Istituto Oncologico della Svizzera Italiana, Bellinzona, Switzerland $1 https://orcid.org/0000000202703805
700    1_
$a Dargenio, Michelina $u Ospedale Vito Fazzi, Lecce, Italy
700    1_
$a Biernat, Monika M $u Department of Haematology, Blood Neoplasms, and Bone Marrow Transplantation, Wroclaw Medical University, Wroclaw, Poland $1 https://orcid.org/0000000331613398
700    1_
$a Sciumè, Mariarita $u Hematology Unit, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy $1 https://orcid.org/0000000179584966
700    1_
$a de Ramón, Cristina $u Hematology Department, Hospital Universitario de Salamanca, Salamanca, Spain $u Instituto de Investigación Biomédica de Salamanca, Centro de Investigación del Cáncer-IBMCC (USAL-CSIC), Salamanca, Spain $1 https://orcid.org/0000000281676410
700    1_
$a de Jonge, Nick $u Amsterdam UMC, location VUmc, Amsterdam, the Netherlands $1 https://orcid.org/0000000299010887
700    1_
$a Batinić, Josip $u University Hospital Centre Zagreb, Zagreb, Croatia $u Croatian Cooperative Group for Hematological Diseases (CROHEM), Croatia $u Faculty of Medicine University of Zagreb, Zagreb, Croatia $1 https://orcid.org/0000000155959911
700    1_
$a Aujayeb, Avinash $u Northumbria Healthcare, Newcastle, United Kingdom $1 https://orcid.org/0000000208595550
700    1_
$a Marchetti, Monia $u Azienda Ospedaliera Nazionale SS. Antonio e Biagio e Cesare Arrigo, Alessandria, Italy $1 https://orcid.org/0000000176150572
700    1_
$a Fouquet, Guillemette $u Cochin Hospital, Assistance Publique - Hôpitaux de Paris, Paris, France $1 https://orcid.org/000000023751393X
700    1_
$a Fernández, Noemí $u Hospital Universitario Marqués de Valdecilla, Santander, Spain
700    1_
$a Zambrotta, Giovanni $u Azienda Ospedaliera San Gerardo - Monza, Monza, Italy $u Università Milano-Bicocca, Milan, Italy $1 https://orcid.org/0000000286122994
700    1_
$a Sacchi, Maria Vittoria $u Azienda Ospedaliera Nazionale SS. Antonio e Biagio e Cesare Arrigo, Alessandria, Italy $1 https://orcid.org/0000000181333357
700    1_
$a Guidetti, Anna $u Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy $1 https://orcid.org/0000000241956397
700    1_
$a Demirkan, Fatih $u Dokuz Eylul University, Division of Hematology, Izmir, Turkey $1 https://orcid.org/0000000211728668
700    1_
$a Prezioso, Lucia $u Hospital University of Parma - Hematology and Bone Marrow Unit, Parma, Italy $1 https://orcid.org/0000000316604960
700    1_
$a Ráčil, Zdeněk $u Institute of Hematology and Blood Transfusion, Prague, Czech Republic $u Department of Physiology, Faculty of Medicine, Masaryk University, Brno, Czech Republic $1 https://orcid.org/0000000335114596
700    1_
$a Nucci, Marcio $u Department of Internal Medicine, Federal University of Rio de Janeiro, Rio de Janeiro, Brazil $1 https://orcid.org/0000000348670014
700    1_
$a Mladenović, Miloš $u COVID hospital "Batajnica," Belgrade, Serbia $1 https://orcid.org/0000000283502182
700    1_
$a Liévin, Raphaël $u Hopital Saint Louis, Paris, France $1 https://orcid.org/000000025097591X
700    1_
$a Hanáková, Michaela $u Institute of Hematology and Blood Transfusion, Prague, Czech Republic $u Department of Physiology, Faculty of Medicine, Masaryk University, Brno, Czech Republic
700    1_
$a Gräfe, Stefanie $u Department I of Internal Medicine, Faculty of Medicine and University Hospital Cologne, Excellence Center for Medical Mycology, University of Cologne, Cologne, Germany $u Faculty of Medicine and University Hospital Cologne, Cologne Excellence Cluster on Cellular Stress Responses in Aging-Associated Diseases, University of Cologne, Cologne, Germany $u Universitätsklinikum Hamburg Eppendorf, Hamburg, Germany $1 https://orcid.org/0000000176780179
700    1_
$a Sili, Uluhan $u Marmara University, Istanbul, Turkey $1 https://orcid.org/0000000299399298
700    1_
$a Machado, Marina $u Clinical Microbiology and Infectious Diseases Department, Hospital General Universitario Gregorio Marañón, Madrid, Spain $1 https://orcid.org/0000000283702248
700    1_
$a Cattaneo, Chiara $u Hematology Unit, ASST-Spedali Civili, Brescia, Italy $1 https://orcid.org/0000000300313237
700    1_
$a Adžić-Vukičević, Tatjana $u COVID hospital "Batajnica," Belgrade, Serbia
700    1_
$a Verga, Luisa $u Azienda Ospedaliera San Gerardo - Monza, Monza, Italy $u Università Milano-Bicocca, Milan, Italy $1 https://orcid.org/0000000208683358
700    1_
$a Labrador, Jorge $u Department of Hematology, Hospital Universitario de Burgos, Burgos, Spain $1 https://orcid.org/0000000236960287
700    1_
$a Rahimli, Laman $u Department I of Internal Medicine, Faculty of Medicine and University Hospital Cologne, Excellence Center for Medical Mycology, University of Cologne, Cologne, Germany $u Faculty of Medicine and University Hospital Cologne, Cologne Excellence Cluster on Cellular Stress Responses in Aging-Associated Diseases, University of Cologne, Cologne, Germany
700    1_
$a Bonanni, Matteo $u Hematology Unit, Fondazione Policlinico Universitario Agostino Gemelli - IRCCS, Rome, Italy $u Hematology Unit, Università Cattolica del Sacro Cuore, Rome, Italy
700    1_
$a Passamonti, Francesco $u Department of Medicine and Surgery, University of Insubria and ASST Sette Laghi, Ospedale di Circolo of Varese, Varese, Italy $1 https://orcid.org/0000000180685289
700    1_
$a Pagliuca, Antonio $u Department of Hematological Medicine, King's College Hospital NHS Foundation Trust, Kings College London & Anthony Nolan, London, United Kingdom $1 https://orcid.org/0000000325190333
700    1_
$a Corradini, Paolo $u University of Milan and Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy $1 https://orcid.org/0000000291861353
700    1_
$a Hoenigl, Martin $u Division of Infectious Diseases and Global Public Health, Department of Medicine, University of California San Diego, San Diego, CA $u Clinical and Translational Fungal-Working Group, University of California San Diego, La Jolla, CA $u Division of Infectious Diseases, Department of Internal Medicine, Medical University of Graz, Graz, Austria $1 https://orcid.org/0000000216532824
700    1_
$a Koehler, Philipp $u Department I of Internal Medicine, Faculty of Medicine and University Hospital Cologne, Excellence Center for Medical Mycology, University of Cologne, Cologne, Germany $u Faculty of Medicine and University Hospital Cologne, Cologne Excellence Cluster on Cellular Stress Responses in Aging-Associated Diseases, University of Cologne, Cologne, Germany $u Faculty of Medicine and University Hospital Cologne, Center for Molecular Medicine Cologne, University of Cologne, Cologne, Germany $1 https://orcid.org/0000000273867495
700    1_
$a Busca, Alessandro $u Stem Cell Transplant Center, AOU Citta' della Salute e della Scienza, Turin, Italy $1 https://orcid.org/0000000153615613
700    1_
$a Cornely, Oliver A $u Department I of Internal Medicine, Faculty of Medicine and University Hospital Cologne, Excellence Center for Medical Mycology, University of Cologne, Cologne, Germany $u Faculty of Medicine and University Hospital Cologne, Center for Molecular Medicine Cologne, University of Cologne, Cologne, Germany $u Faculty of Medicine and University Hospital Cologne, Chair Translational Research, Cologne Excellence Cluster on Cellular Stress Responses in Aging-Associated Diseases (CECAD), University of Cologne, Cologne, Germany $u Faculty of Medicine and University Hospital Cologne, Clinical Trials Centre Cologne (ZKS Köln), University of Cologne, Cologne, Germany $u German Centre for Infection Research (DZIF), Partner Site Bonn-Cologne, Cologne, Germany $1 https://orcid.org/0000000195993137
773    0_
$w MED00000807 $t Blood $x 1528-0020 $g Roč. 140, č. 26 (2022), s. 2773-2787
856    41
$u https://pubmed.ncbi.nlm.nih.gov/36126318 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y p $z 0
990    __
$a 20230418 $b ABA008
991    __
$a 20230425171748 $b ABA008
999    __
$a ok $b bmc $g 1925141 $s 1191078
BAS    __
$a 3
BAS    __
$a PreBMC-MEDLINE
BMC    __
$a 2022 $b 140 $c 26 $d 2773-2787 $e 2022Dec29 $i 1528-0020 $m Blood $n Blood $x MED00000807
LZP    __
$a Pubmed-20230418

Najít záznam

Citační ukazatele

Možnosti archivace